Variability exists in a number of aspects of community-acquired pneumonia (CAP) management, including initial laboratory testing 1 and antibiotic prescribing. 2, 3 Care variation contributes to increased costs and disparate outcomes. [4] [5] [6] Clinical practice guidelines (CPGs) can favorably influence utilization and clinical outcomes by developing evidence-based, peer-reviewed recommendations for patient care. 4, 7, 8 In a study of children hospitalized with urinary tract infection, hospitals with a CPG for this condition had a 20% shorter length of stay (LOS) and total charges that were $1060 less per admission than hospitals without a similar CPG. 4 The introduction of an institutional CPG for bronchiolitis was also associated with reduction of resource utilization, including chest physiotherapy and respiratory syncytial virus testing. 8 Application of nationally published guidelines for acute gastroenteritis lowered charges in emergency departments and observation units by 50% without any adverse outcomes. 5 Recently, implementation of an institutional CPG for CAP supported by an antibiotic stewardship program was associated with an increase in narrow-spectrum antibiotic use without increases in adverse outcomes. 9 Consensus national guidelines for the care of pediatric CAP were published in 2011 by the Pediatric Infectious Diseases Society (PIDS) and the Infectious Diseases Society of America (IDSA). 10 These guidelines may serve as a resource for institutional CPG development. The objectives of this study were to describe characteristics of institutional pneumonia CPGs before publication of the Consensus National Guidelines, and to determine whether the presence or absence of an institutional CPG was associated with differences in clinical management of patients across institutions.
METHODS

Data Source
Data for this multicenter retrospective cohort study were obtained from the Pediatric Health Information System, which contains resource utilization data from 43 freestanding tertiary care children' s hospitals with emergency departments. Participating hospitals are located in noncompeting markets of 27 states plus the District of Columbia and accounted for 15% of all pediatric hospitalizations in the United States in 2009 (677 291 of 4 508 323 admissions). 11, 12 These hospitals provide discharge data, including patient demographics, diagnoses, and procedures. Billing data detail all drugs, radiologic imaging studies, laboratory tests, and supplies charged to each patient. Data are de-identified before inclusion in the database; however, encrypted medical record numbers allow for tracking individual patients across admissions. The Children' s Hospital Association (Overland Park, KS) and participating hospitals jointly ensure data quality as described previously. 13, 14 In accordance with the Common Rule (45 CFR 46.102[f]) and the policies of the Cincinnati Children' s Hospital Medical Center Institutional Review Board, this research, using a de-identified data set, was not considered human subjects research.
Questionnaire
A survey was sent to the quality officer at each participating hospital to determine whether the institution had a CPG addressing the treatment of children with CAP. Hospitals that responded to the questionnaire stating that they did have a CPG were asked to share them. All institutions reporting the use of a CAP CPG provided the actual CPG for review.
Patients
Children, 1 to 18 years of age, hospitalized for CAP were eligible for this study if they were discharged from participating hospitals between July Children were excluded for the following reasons: (1) interhospital transfer; (2) chronic comorbid condition predisposing to severe, recurrent, or health care-associated pneumonia (eg, cystic fibrosis, malignancy, sickle cell disease) as defined by a previously reported classification scheme 15 ; and (3) no antibiotic therapy on the first calendar day of hospitalization, suggesting that pneumonia was not present or diagnosed at the time of admission. To create a cohort of children presenting with nonsevere CAP, we additionally excluded children who were admitted to an ICU or died during the first calendar day of hospitalization. 1 We also excluded children who underwent a pleural drainage procedure. These were identified by using International Classification of Diseases, Ninth Revision, procedure codes for thoracentesis (34.91), chest tube placement (34.04), video-assisted thoracoscopic surgery (34.21), and thoracotomy (34.02 or 34.09).
Measured Exposures
The primary exposure of interest was the hospital availability of a CPG for CAP. The CPGs were classified by whether they addressed 6 diagnostic tests (complete blood count [CBC] , serum electrolytes, blood culture, C-reactive protein, respiratory tract viral testing, and chest radiographs [CXRs] ) and antibiotic therapy, specifically the use of penicillin/aminopenicillins or macrolides. The CPGs were grouped by whether each test or therapy was recommended for, recommended against, or not mentioned. Each CPG was reviewed by 2 investigators (M.I.N. and A.L.H.), by using a standardized template for data abstraction, and discrepancies were resolved by group consensus.
Measured Outcomes
The measured outcomes were hospital LOS, readmission within 14 days of index discharge, cost of hospitalization, performance of diagnostic testing, and antibiotic selection. Total cost was calculated for the index hospitalization as well as for the episode of illness, which included the index visit and any subsequent emergency department visits and hospitalizations within 14 days. Total hospital charges in the Pediatric Health Information System database were adjusted for hospital location by using the Centers for Medicare and Medicaid price/wage index. We used hospital-level cost-to-charge ratios to convert the charges to costs. Performance of diagnostic testing and antibiotic administration were assessed based on the presence or absence of specific recommendations pertaining to that test or antibiotic within the CPGs.
Statistical Analysis
Hospital level covariates were summarized by using median and interquartile range (IQR) values for continuous variables, and frequencies and percentages for categorical variables. We compared median LOS and median hospitalization and episode costs by using the Wilcoxon rank-sum test. We assessed the relationship between presence of CPG and of CPG recommendations and diagnostic testing by using x 2 statistics. We also assessed the relationship between the use of penicillin/aminopenicillins or macrolides and the presence of a CPG and of CPG recommendations. Furthermore, we compared rates of testing by the presence of a CPG and by CPG recommendations. To account for the clustering of patients within hospitals, we used generalized estimating equations to generate adjusted odds ratios (ORs) and 95% confidence intervals (CIs).
All statistical analyses were performed by using the statistical software SAS (version 9.3, SAS Institute, Inc, Cary, NC), and P values ,.05 were considered statistically significant.
RESULTS
Availability of a CAP CPG
Forty-one (95%) of the 43 hospitals surveyed completed the questionnaire, and 13 (32%) of 41 reported having an institutional CPG for CAP. Of the 13 institutions with a CPG, the guideline was in the form of a written algorithm in 8 institutions, of which, only 4 provided supporting evidence for the recommendations provided. Five institutions used a clinical guideline in the form of electronic order entry; 2 of these institutions also had a supporting document that provided the evidence for the recommendations cited.
There was marked variability in the specific recommendations around diagnostic testing contained within the CPGs (Table 1) . Some of the variability in testing recommendations was attributable to whether the testing was mentioned within the CPG (eg, CXR), whereas the performance of other tests varied based on the specific recommendation itself. For example, 6 institutions recommended obtaining a CBC, whereas 1 institution recommended against obtaining a CBC. Five institutions recommended obtaining a CBC only if the results would help to decide on or guide antimicrobial therapy (ie, obtain conditionally). CBC was not mentioned in 1 CPG.
Patient Characteristics
During the 2-year study period, 38 957 children were hospitalized at the participating institutions with a diagnosis of CAP. After selection criteria were applied (Fig 1) , the final cohort included 19 710 children classified as having nonsevere CAP. Most children (70%) were between 1 and 5 years of age; children 6 to 12 years and 13 to 18 years accounted for 24% and 6% of patients, respectively. Approximately 52% of patients were male. Patient race included non-Hispanic white (45%), non-Hispanic black (25%), Hispanic (26%), Asian (4%), and other races (,1%). Hospitalizations were most common in the winter months (38%). Over the 2-year study period, the median number of hospitalizations at each institution was 395 (IQR, 303-682). Median hospital LOS was 2 days (IQR, 1-3 days).
Across all institutions, independent of the presence of a CPG, the use of laboratory testing was higher among older children, whereas viral testing was performed more commonly in younger children. Penicillin or aminopenicillins were used as first-line agents more often for children 1 to 5 years of age, and macrolides were more frequently used (either alone or in combination) in older children (Table 2) .
CPGs and LOS, Readmissions, and Costs
There was no difference in the hospital LOS between those institutions with and without a CAP CPG (median 2.0 days [IQR, [1] [2] [3] in both groups; P = .269). The proportion of children readmitted within 14 days did not vary based on the availability of a CPG (2.3% vs 2.1%; P = .4). Additionally, the presence of a CAP CPG was not associated with either differences in the cost of hospitalization for the index visit, or the total cost for the episode of illness (including repeat visits with hospitalization within 14 days) ( Table 3) . 
CPGs and Use of Diagnostic Testing
Guideline recommendations for diagnostic testing were not significantly associated with care patterns for children hospitalized with pneumonia. Although blood testing (CBC, serum electrolytes, blood culture) was performed more often when specifically recommended in the guideline, the odds of obtaining these tests did not significantly differ from patients cared for at institutions where the guideline did not mention these specific diagnostic tests, or from institutions without a pneumonia guideline after adjustment for hospital clustering (Table 4) . However, children cared for at institutions with a CPG that recommended viral testing, such as influenza or respiratory syncytial virus testing, were more likely to have this testing performed compared with children cared for at institutions without a CPG (38.7% vs 28.0%, respectively; OR 1.6, 95% CI 1.0-2.6).
Children cared for at institutions that recommended obtaining a C-reactive protein level were also more likely to have this test performed (OR 4.8, 95% CI 2.3-10.2) compared with children cared for at institutions without a CPG. There was no difference in the rate of obtaining a CXR between patients cared for at institutions with and without a CAP CPG. We did not evaluate the performance of sputum Gram stain and culture, as they were rarely mentioned within the CPGs, and were performed in only 0.4% of patients in the study.
CPGs and Antibiotic Selection
Antibiotic choice was associated with specific CPG recommendations. Penicillin or aminopenicillins were more likely to be used as first-line agents in children cared for at institutions where a CPG recommended the use of these antibiotics as first-line therapy compared with children evaluated at an institution without a CPG (46.3% vs 23.9%, adjusted OR 2.7; 95% CI 1.4-5.5) ( Table 5 ). Macrolides were used less often among children older than 5 years of age when cared for at an institution using a CPG that did not specifically address criteria for use of a macrolide antibiotic compared with children cared for at institutions without CPGs (OR 0.6, 95% CI 0.3-0.9).
DISCUSSION
We described institutional CAP CPGs from tertiary care children' s hospitals and evaluated their impact on hospitalized children. The presence, form, and content of CPGs for the management of hospitalized children with CAP varied widely. The presence of a CAP CPG itself was not associated with the hospital LOS, 14-day readmission rate, or total cost of hospitalization. With the exception of viral testing, the presence of a CPG was not associated with diagnostic testing. On the other hand, CPGs were associated with narrowspectrum antibiotic use.
Our findings suggest that test-ordering patterns are difficult to influence with a guideline alone, and underscore the challenges inherent in changing clinical practice according to best evidence. A potential reason why testing and treatment of children with CAP guidelines did not match institutional guideline recommendations may lie in the fact that the evidence supporting such recommendations is weak. Clinical inertia, and lack of awareness regarding CPGs, may also reduce the Obtain (6) Obtain (2) Obtain (6) Obtain (2) Obtain (3) Obtain (8) Do not obtain (1) Do not obtain (0) Do not obtain (4) Do not obtain (2) Do not obtain (1) Do not obtain (0) Conditional (5) Conditional (0) Conditional (1) Conditional (2) Conditional (2) Conditional (0) Not mentioned (1) Not mentioned (11) Not mentioned (2) Not mentioned (7) Not mentioned (7) Not mentioned (5) RSV, respiratory syncytial virus. a Obtain if results of testing may help to identify or raise suspicion of bacterial etiology (for analyses, these classified as do not obtain).
impact of guidelines. 16 In contrast to diagnostic testing, recommendations for antibiotic selection were more readily followed in our study, a finding that is consistent with previous studies. 17, 18 It is possible that once a decision is made to treat a patient with antimicrobial agents, the decision regarding specific antibiotic use may be easier to influence than the decision around whether to obtain a specific diagnostic test. Regardless, the formulation of evidence-based practice recommendations is only the first step in the process of implementing health care interventions, and institutional guideline development should be accompanied by the creation of effective dissemination, implementation, and evaluation strategies to ensure maximum impact.
Evidence-based practice guidelines have been developed to standardize the management of patients with a specific diagnosis. The Institute of Medicine published a reference guide that outlines the key elements for the development and updating of CPGs. 19 In this document, the Institute of Medicine recommends that for each recommendation listed on a CPG, an explanation of the reasoning underlying the recommendation should be provided. In our study, only half of the guidelines provided supporting evidence for the recommendations provided. Additionally, the recommendations provided within the CPGs varied among institutions, which supports the notion that a consensus on the best practices for the management of CAP is not standard among similar children' s hospitals. This is likely because of the variability in expert opinion around optimal management strategies for children hospitalized with CAP. 3 The recently published national consensus PIDS/ IDSA guidelines summarize the evidence base for the key elements of diagnostic testing and treatment of the management of children with CAP, which may be helpful for future institutional guideline development. 10 A major goal of CPGs is to improve patient outcomes. The American Thoracic Society and IDSA developed guidelines for the management of adults with CAP independently in 1993 20 and 2001, 21 but
FIGURE 1
Flow diagram of study cohort. CCC, chronic comorbid condition. in 2007 developed a joint guideline. 22 Guideline concordant therapy was associated with a reduction in mortality and LOS for adults with CAP. 23 In our study of children, the presence of institutional CPGs for management of CAP was not associated with differences in clinical outcomes, such as LOS, readmission, or cost. These measures may be too broad to detect small differences associated with CPG presence, and the varied nature of the recommendations within the CPGs also diminishes our ability to detect differences in patient outcomes. The recently published PIDS/IDSA pneumonia guidelines provide an easily accessible and common national set of recommendations for the diagnosis and management of children with CAP 10 ; however, future efforts must focus on guideline implementation and outcome measurement on a local level.
An important finding in this study was the greater use of narrow-spectrum antibiotics, such as penicillin and aminopenicillins, among patients admitted to hospitals with CPGs that recommended those antibiotics. Newman and colleagues 9 recently demonstrated that after an introduction of an antimicrobial stewardship program and a CAP CPG, the use of ampicillin increased by 34%, whereas ceftriaxone use decreased by 47%, without an increase in treatment failures. A particularly important finding was that more patients were subsequently discharged on amoxicillin after the implementation of the guideline. Although data on discharge medications cannot be ascertained from our current data set, it is likely that patients cared for in hospitals with guidelines also were discharged from the hospital with a narrower spectrum agent. Previous studies have shown that clinical outcomes among children treated with narrow-spectrum antibiotics for CAP are equivalent to those treated with broad-spectrum antibiotics, which underlies the current guideline recommendations from the IDSA. 2, 24 This study had several limitations. First, our assessment of the presence of a CPG was based on responses received from the quality directors at each institution. Although we confirmed the presence of a CPG by manual review of the guidelines, we are unable to confirm the absence of a CPG for institutions reporting no guideline. We were also unable to determine the manner and extent to which the individual CPGs were disseminated within each institution, a factor that could influence its impact. Second, categorization of specific recommendations around diagnostic testing within the guidelines may be subject to reviewer bias, although we had 2 reviewers assess and categorize each recommendation contained within the guideline and final classification was based on reviewers' consensus. Third, CPGs were in various formats, including algorithms, written recommendations, and order sets, making the evaluation and categorization of such guidelines difficult. Fourth, although our study was restricted to a relatively homogeneous group of patients without evidence of severe or complicated disease at admission, there remains the possibility of residual confounding by disease severity. We defined pneumonia by physicianassigned discharge diagnosis codes. It can be challenging to distinguish bacterial CAP from viral lower respiratory tract infection, and it is likely that some patients with viral lower respiratory tract infection were included; however, given the lack of a gold standard to diagnose bacterial pneumonia, this limitation is unavoidable and also mirrors clinical practice. We do not expect this limitation to meaningfully affect our results, as our intent was to determine the association between local CPGs and management of children suspected of having CAP by the treating physician. The accuracy of the diagnosis, although important clinically, is less critical to this study.
CONCLUSIONS
We observed wide variability in the presence, form, and content of CAP guidelines among children' s hospitals. This heterogeneity poses challenges in evaluating the impact of guidelines on resource utilization and outcomes. Although CAP guidelines were not significantly associated with diagnostic testing or clinical outcomes, they were associated with narrow-spectrum antibiotic use. The recent publication of consensus guidelines may help to standardize the approach to the care of the child with pneumonia. Strategies aimed at optimizing the implementation, dissemination, and evaluation of clinical guidelines will be needed to truly impact patient care. 
